The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI for Cancer Diagnosis Market Research Report 2025
Synopsis
The global market for AI for Cancer Diagnosis was valued at US$ 224 million in the year 2024 and is projected to reach a revised size of US$ 1661 million by 2031, growing at a CAGR of 33.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI for Cancer Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI for Cancer Diagnosis.
The AI for Cancer Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI for Cancer Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI for Cancer Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lunit Inc
Xilis
Shukun Technology
Kheiron
SkinVision
Infervision
Imagene AI
Oncora Medical
Niramai Health Analytix
Enlitic
Maxwell Plus
Therapixel
Ibex
OrigiMed
Tencent
Segment by Type
Breast Cancer
Lung Cancer
Prostatic Cancer
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI for Cancer Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for AI for Cancer Diagnosis was valued at US$ 224 million in the year 2024 and is projected to reach a revised size of US$ 1661 million by 2031, growing at a CAGR of 33.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI for Cancer Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI for Cancer Diagnosis.
The AI for Cancer Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI for Cancer Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI for Cancer Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lunit Inc
Xilis
Shukun Technology
Kheiron
SkinVision
Infervision
Imagene AI
Oncora Medical
Niramai Health Analytix
Enlitic
Maxwell Plus
Therapixel
Ibex
OrigiMed
Tencent
Segment by Type
Breast Cancer
Lung Cancer
Prostatic Cancer
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI for Cancer Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI for Cancer Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Breast Cancer
1.2.3 Lung Cancer
1.2.4 Prostatic Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI for Cancer Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI for Cancer Diagnosis Market Perspective (2020-2031)
2.2 Global AI for Cancer Diagnosis Growth Trends by Region
2.2.1 Global AI for Cancer Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI for Cancer Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 AI for Cancer Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 AI for Cancer Diagnosis Market Dynamics
2.3.1 AI for Cancer Diagnosis Industry Trends
2.3.2 AI for Cancer Diagnosis Market Drivers
2.3.3 AI for Cancer Diagnosis Market Challenges
2.3.4 AI for Cancer Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI for Cancer Diagnosis Players by Revenue
3.1.1 Global Top AI for Cancer Diagnosis Players by Revenue (2020-2025)
3.1.2 Global AI for Cancer Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global AI for Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI for Cancer Diagnosis Revenue
3.4 Global AI for Cancer Diagnosis Market Concentration Ratio
3.4.1 Global AI for Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI for Cancer Diagnosis Revenue in 2024
3.5 Global Key Players of AI for Cancer Diagnosis Head office and Area Served
3.6 Global Key Players of AI for Cancer Diagnosis, Product and Application
3.7 Global Key Players of AI for Cancer Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI for Cancer Diagnosis Breakdown Data by Type
4.1 Global AI for Cancer Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global AI for Cancer Diagnosis Forecasted Market Size by Type (2026-2031)
5 AI for Cancer Diagnosis Breakdown Data by Application
5.1 Global AI for Cancer Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global AI for Cancer Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI for Cancer Diagnosis Market Size (2020-2031)
6.2 North America AI for Cancer Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI for Cancer Diagnosis Market Size by Country (2020-2025)
6.4 North America AI for Cancer Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI for Cancer Diagnosis Market Size (2020-2031)
7.2 Europe AI for Cancer Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI for Cancer Diagnosis Market Size by Country (2020-2025)
7.4 Europe AI for Cancer Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI for Cancer Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific AI for Cancer Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI for Cancer Diagnosis Market Size (2020-2031)
9.2 Latin America AI for Cancer Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI for Cancer Diagnosis Market Size by Country (2020-2025)
9.4 Latin America AI for Cancer Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI for Cancer Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa AI for Cancer Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lunit Inc
11.1.1 Lunit Inc Company Details
11.1.2 Lunit Inc Business Overview
11.1.3 Lunit Inc AI for Cancer Diagnosis Introduction
11.1.4 Lunit Inc Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.1.5 Lunit Inc Recent Development
11.2 Xilis
11.2.1 Xilis Company Details
11.2.2 Xilis Business Overview
11.2.3 Xilis AI for Cancer Diagnosis Introduction
11.2.4 Xilis Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.2.5 Xilis Recent Development
11.3 Shukun Technology
11.3.1 Shukun Technology Company Details
11.3.2 Shukun Technology Business Overview
11.3.3 Shukun Technology AI for Cancer Diagnosis Introduction
11.3.4 Shukun Technology Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.3.5 Shukun Technology Recent Development
11.4 Kheiron
11.4.1 Kheiron Company Details
11.4.2 Kheiron Business Overview
11.4.3 Kheiron AI for Cancer Diagnosis Introduction
11.4.4 Kheiron Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.4.5 Kheiron Recent Development
11.5 SkinVision
11.5.1 SkinVision Company Details
11.5.2 SkinVision Business Overview
11.5.3 SkinVision AI for Cancer Diagnosis Introduction
11.5.4 SkinVision Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.5.5 SkinVision Recent Development
11.6 Infervision
11.6.1 Infervision Company Details
11.6.2 Infervision Business Overview
11.6.3 Infervision AI for Cancer Diagnosis Introduction
11.6.4 Infervision Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.6.5 Infervision Recent Development
11.7 Imagene AI
11.7.1 Imagene AI Company Details
11.7.2 Imagene AI Business Overview
11.7.3 Imagene AI AI for Cancer Diagnosis Introduction
11.7.4 Imagene AI Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.7.5 Imagene AI Recent Development
11.8 Oncora Medical
11.8.1 Oncora Medical Company Details
11.8.2 Oncora Medical Business Overview
11.8.3 Oncora Medical AI for Cancer Diagnosis Introduction
11.8.4 Oncora Medical Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.8.5 Oncora Medical Recent Development
11.9 Niramai Health Analytix
11.9.1 Niramai Health Analytix Company Details
11.9.2 Niramai Health Analytix Business Overview
11.9.3 Niramai Health Analytix AI for Cancer Diagnosis Introduction
11.9.4 Niramai Health Analytix Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.9.5 Niramai Health Analytix Recent Development
11.10 Enlitic
11.10.1 Enlitic Company Details
11.10.2 Enlitic Business Overview
11.10.3 Enlitic AI for Cancer Diagnosis Introduction
11.10.4 Enlitic Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.10.5 Enlitic Recent Development
11.11 Maxwell Plus
11.11.1 Maxwell Plus Company Details
11.11.2 Maxwell Plus Business Overview
11.11.3 Maxwell Plus AI for Cancer Diagnosis Introduction
11.11.4 Maxwell Plus Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.11.5 Maxwell Plus Recent Development
11.12 Therapixel
11.12.1 Therapixel Company Details
11.12.2 Therapixel Business Overview
11.12.3 Therapixel AI for Cancer Diagnosis Introduction
11.12.4 Therapixel Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.12.5 Therapixel Recent Development
11.13 Ibex
11.13.1 Ibex Company Details
11.13.2 Ibex Business Overview
11.13.3 Ibex AI for Cancer Diagnosis Introduction
11.13.4 Ibex Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.13.5 Ibex Recent Development
11.14 OrigiMed
11.14.1 OrigiMed Company Details
11.14.2 OrigiMed Business Overview
11.14.3 OrigiMed AI for Cancer Diagnosis Introduction
11.14.4 OrigiMed Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.14.5 OrigiMed Recent Development
11.15 Tencent
11.15.1 Tencent Company Details
11.15.2 Tencent Business Overview
11.15.3 Tencent AI for Cancer Diagnosis Introduction
11.15.4 Tencent Revenue in AI for Cancer Diagnosis Business (2020-2025)
11.15.5 Tencent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global AI for Cancer Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Breast Cancer
Table 3. Key Players of Lung Cancer
Table 4. Key Players of Prostatic Cancer
Table 5. Key Players of Others
Table 6. Global AI for Cancer Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI for Cancer Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global AI for Cancer Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global AI for Cancer Diagnosis Market Share by Region (2020-2025)
Table 10. Global AI for Cancer Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global AI for Cancer Diagnosis Market Share by Region (2026-2031)
Table 12. AI for Cancer Diagnosis Market Trends
Table 13. AI for Cancer Diagnosis Market Drivers
Table 14. AI for Cancer Diagnosis Market Challenges
Table 15. AI for Cancer Diagnosis Market Restraints
Table 16. Global AI for Cancer Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global AI for Cancer Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top AI for Cancer Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI for Cancer Diagnosis as of 2024)
Table 19. Ranking of Global Top AI for Cancer Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by AI for Cancer Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of AI for Cancer Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of AI for Cancer Diagnosis, Product and Application
Table 23. Global Key Players of AI for Cancer Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI for Cancer Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global AI for Cancer Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global AI for Cancer Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global AI for Cancer Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global AI for Cancer Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global AI for Cancer Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global AI for Cancer Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global AI for Cancer Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America AI for Cancer Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America AI for Cancer Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe AI for Cancer Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe AI for Cancer Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific AI for Cancer Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific AI for Cancer Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America AI for Cancer Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America AI for Cancer Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa AI for Cancer Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa AI for Cancer Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. Lunit Inc Company Details
Table 49. Lunit Inc Business Overview
Table 50. Lunit Inc AI for Cancer Diagnosis Product
Table 51. Lunit Inc Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 52. Lunit Inc Recent Development
Table 53. Xilis Company Details
Table 54. Xilis Business Overview
Table 55. Xilis AI for Cancer Diagnosis Product
Table 56. Xilis Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 57. Xilis Recent Development
Table 58. Shukun Technology Company Details
Table 59. Shukun Technology Business Overview
Table 60. Shukun Technology AI for Cancer Diagnosis Product
Table 61. Shukun Technology Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 62. Shukun Technology Recent Development
Table 63. Kheiron Company Details
Table 64. Kheiron Business Overview
Table 65. Kheiron AI for Cancer Diagnosis Product
Table 66. Kheiron Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 67. Kheiron Recent Development
Table 68. SkinVision Company Details
Table 69. SkinVision Business Overview
Table 70. SkinVision AI for Cancer Diagnosis Product
Table 71. SkinVision Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 72. SkinVision Recent Development
Table 73. Infervision Company Details
Table 74. Infervision Business Overview
Table 75. Infervision AI for Cancer Diagnosis Product
Table 76. Infervision Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 77. Infervision Recent Development
Table 78. Imagene AI Company Details
Table 79. Imagene AI Business Overview
Table 80. Imagene AI AI for Cancer Diagnosis Product
Table 81. Imagene AI Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Imagene AI Recent Development
Table 83. Oncora Medical Company Details
Table 84. Oncora Medical Business Overview
Table 85. Oncora Medical AI for Cancer Diagnosis Product
Table 86. Oncora Medical Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 87. Oncora Medical Recent Development
Table 88. Niramai Health Analytix Company Details
Table 89. Niramai Health Analytix Business Overview
Table 90. Niramai Health Analytix AI for Cancer Diagnosis Product
Table 91. Niramai Health Analytix Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Niramai Health Analytix Recent Development
Table 93. Enlitic Company Details
Table 94. Enlitic Business Overview
Table 95. Enlitic AI for Cancer Diagnosis Product
Table 96. Enlitic Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 97. Enlitic Recent Development
Table 98. Maxwell Plus Company Details
Table 99. Maxwell Plus Business Overview
Table 100. Maxwell Plus AI for Cancer Diagnosis Product
Table 101. Maxwell Plus Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 102. Maxwell Plus Recent Development
Table 103. Therapixel Company Details
Table 104. Therapixel Business Overview
Table 105. Therapixel AI for Cancer Diagnosis Product
Table 106. Therapixel Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 107. Therapixel Recent Development
Table 108. Ibex Company Details
Table 109. Ibex Business Overview
Table 110. Ibex AI for Cancer Diagnosis Product
Table 111. Ibex Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 112. Ibex Recent Development
Table 113. OrigiMed Company Details
Table 114. OrigiMed Business Overview
Table 115. OrigiMed AI for Cancer Diagnosis Product
Table 116. OrigiMed Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 117. OrigiMed Recent Development
Table 118. Tencent Company Details
Table 119. Tencent Business Overview
Table 120. Tencent AI for Cancer Diagnosis Product
Table 121. Tencent Revenue in AI for Cancer Diagnosis Business (2020-2025) & (US$ Million)
Table 122. Tencent Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. AI for Cancer Diagnosis Picture
Figure 2. Global AI for Cancer Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI for Cancer Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Breast Cancer Features
Figure 5. Lung Cancer Features
Figure 6. Prostatic Cancer Features
Figure 7. Others Features
Figure 8. Global AI for Cancer Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global AI for Cancer Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. AI for Cancer Diagnosis Report Years Considered
Figure 14. Global AI for Cancer Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global AI for Cancer Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global AI for Cancer Diagnosis Market Share by Region: 2024 VS 2031
Figure 17. Global AI for Cancer Diagnosis Market Share by Players in 2024
Figure 18. Global Top AI for Cancer Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI for Cancer Diagnosis as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by AI for Cancer Diagnosis Revenue in 2024
Figure 20. North America AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America AI for Cancer Diagnosis Market Share by Country (2020-2031)
Figure 22. United States AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe AI for Cancer Diagnosis Market Share by Country (2020-2031)
Figure 26. Germany AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific AI for Cancer Diagnosis Market Share by Region (2020-2031)
Figure 34. China AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America AI for Cancer Diagnosis Market Share by Country (2020-2031)
Figure 42. Mexico AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa AI for Cancer Diagnosis Market Share by Country (2020-2031)
Figure 46. Turkey AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE AI for Cancer Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Lunit Inc Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 50. Xilis Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 51. Shukun Technology Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 52. Kheiron Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 53. SkinVision Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 54. Infervision Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 55. Imagene AI Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 56. Oncora Medical Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 57. Niramai Health Analytix Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 58. Enlitic Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 59. Maxwell Plus Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 60. Therapixel Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 61. Ibex Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 62. OrigiMed Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 63. Tencent Revenue Growth Rate in AI for Cancer Diagnosis Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
